Cite
MLA Citation
P. Khlyabova et al.. “SAT0040 Safety, tolerability, pharmacokinetics and pharmacodynamics of bcd-089, novel monoclonal anti-il-6 receptor antibody: results from the first-in-human single dose escalation study in healthy volunteers.” Annals of the rheumatic diseases, vol. 77, n.d., pp. 884–885. http://access.bl.uk/ark:/81055/vdc_100144728623.0x000049